List of works by Emma Guttman-Yassky

A Nitric Oxide-releasing Topical Medication as a Potential Treatment Option for Atopic Dermatitis Through Antimicrobial and Anti-inflammatory Activity

scientific article published on 16 May 2020

A Phase 2 Randomized Trial of Apremilast in Patients with Atopic Dermatitis

scientific article published on 05 December 2018

A mild topical steroid leads to progressive anti-inflammatory effects in the skin of patients with moderate-to-severe atopic dermatitis.

scientific article published on 2 March 2016

A novel therapeutic paradigm for patients with extensive alopecia areata

scientific article published on 10 May 2016

A possible role for IL-17A in establishing Th2 inflammation in murine models of atopic dermatitis

scientific article published on August 2014

A preliminary 18F-FDG-PET/MRI study shows increased vascular inflammation in moderate-to-severe atopic dermatitis

scientific article published on 25 July 2020

A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata

scientific article published on 11 November 2018

Absence of Kaposi's sarcoma-associated herpesvirus genome in adenocarcinoma of the colon in patients with concomitant Kaposi's sarcoma

scientific article published on 01 July 2006

Absence of Kaposi's sarcoma-associated herpesvirus in lesions of mycosis fungoides in patients with concomitant Kaposi's sarcoma

scientific article published on 01 August 2004

Accelerated T-cell activation and differentiation of polar subsets characterizes early atopic dermatitis development.

scientific article

Age-specific changes in the molecular phenotype of patients with moderate-to-severe atopic dermatitis

scientific article published on 24 January 2019

Alopecia Areata Is Associated with Atopic Diathesis: Results from a Population-Based Study of 51,561 Patients

scientific article published on 06 February 2020

Alopecia Areata: A Complex Cytokine Driven Disease

scientific article published on 01 November 2020

Alopecia areata is characterized by expansion of circulating Th2/Tc2/Th22, within the skin-homing and systemic T-cell populations

scientific article published on 30 October 2017

Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing

scientific article published on 15 August 2015

Alterations in B-cell subsets in pediatric patients with early atopic dermatitis

scientific article published on 10 December 2016

An IL-17-dominant immune profile is shared across the major orphan forms of ichthyosis.

scientific article published on 20 August 2016

An Integrated Model of Atopic Dermatitis Biomarkers Highlights the Systemic Nature of the Disease.

scientific article published on 4 November 2016

An integrated model of alopecia areata biomarkers highlights both TH1 and TH2 upregulation

scientific article published on 05 July 2018

Analysis of alopecia areata surveys suggests a threshold for improved patient‐reported outcomes

scientific article published in 2022

Arginase1 Deficiency in Monocytes/Macrophages Upregulates Inducible Nitric Oxide Synthase To Promote Cutaneous Contact Hypersensitivity.

scientific article published on 26 July 2017

Assessing the current treatment of atopic dermatitis: Unmet needs.

scientific article

Association of Inadequately Controlled Disease and Disease Severity With Patient-Reported Disease Burden in Adults With Atopic Dermatitis

scientific article published on 01 August 2018

Atopic Dermatitis in Diverse Racial and Ethnic Groups - Variations in Epidemiology, Genetics, Clinical Presentation, and Treatment

scientific article published on 19 February 2018

Atopic dermatitis

scientific article published on 01 January 2007

Atopic dermatitis and psoriasis: two different immune diseases or one spectrum?

scientific article published in September 2017

Atopic dermatitis endotypes and implications for targeted therapeutics

scientific article published on 01 January 2019

Atopic dermatitis endotypes based on allergen sensitization, reactivity to Staphylococcus aureus antigens, and underlying systemic inflammation.

scientific article published on 17 August 2019

Atopic dermatitis in African American patients is T2/T22-skewed with T1/T17 attenuation

scientific article published on 14 September 2018

Atopic dermatitis in Chinese patients shows TH2/TH17 skewing with psoriasiform features

scientific article published on 28 June 2018

Atopic dermatitis keratinocytes exhibit normal T(H)17 cytokine responses

scientific article

Atopic dermatitis patients show increases in serum C-reactive protein levels, correlating with skin disease activity

scientific article published in 2017

Atopic dermatitis results in intrinsic barrier and immune abnormalities: implications for contact dermatitis

scientific article

Atopic dermatitis yardstick: Practical recommendations for an evolving therapeutic landscape

scientific article

Atopic dermatitis: pathogenesis.

scientific article published in September 2017

Attenuated neutrophil axis in atopic dermatitis compared to psoriasis reflects TH17 pathway differences between these diseases

scientific article published on 15 June 2013

Author Correction: The atopic dermatitis blood signature is characterized by increases in inflammatory and cardiovascular risk proteins.

scientific article

Baricitinib in adult patients with moderate-to-severe atopic dermatitis: a phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study

scientific article published in February 2018

Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials

scientific article published on 05 January 2020

Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumab

scientific article published on 17 August 2018

Biomarkers of alopecia areata disease activity and response to corticosteroid treatment.

scientific article published on 3 March 2016

Blockade of CD11a by Efalizumab in Psoriasis Patients Induces a Unique State of T-Cell Hyporesponsiveness

scientific article published on 31 January 2008

Blood endotyping distinguishes the profile of vitiligo from that of other inflammatory and autoimmune skin diseases

scientific article published on 18 December 2018

Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis

scientific article published on 01 December 2009

Candidate Predisposition Variants in Kaposi Sarcoma as Detected by Whole-Genome Sequencing

scientific article published on 17 July 2019

Cellular and molecular immunologic mechanisms in patients with atopic dermatitis

scientific article

Characterisation of the cutaneous pathology in non-small cell lung cancer (NSCLC) patients treated with the EGFR tyrosine kinase inhibitor erlotinib

scientific article published on 2 June 2010

Chronic Hand Eczema Guidelines From an Expert Panel of the International Eczema Council

scientific article published on 30 September 2020

Chronic Hand Eczema Understanding Has Ramifications On Clinical Management

scientific article published on 16 March 2020

Classic Kaposi sarcoma. Which KSHV-seropositive individuals are at risk?

scientific article published in January 2006

Clinical Relevance of Skin Pain in Atopic Dermatitis

scientific article published on 01 October 2020

Clinically Meaningful Responses to Dupilumab in Adolescents with Uncontrolled Moderate-to-Severe Atopic Dermatitis: Post-hoc Analyses from a Randomized Clinical Trial

scientific article published on 01 February 2020

Comparing cutaneous molecular improvement with different treatments in atopic dermatitis patients

scientific article published on 16 January 2020

Conjunctivitis in dupilumab clinical trials

scientific article published on 07 May 2019

Contrasting pathogenesis of atopic dermatitis and psoriasis--part I: clinical and pathologic concepts

scientific article published on 08 March 2011

Contrasting pathogenesis of atopic dermatitis and psoriasis--part II: immune cell subsets and therapeutic concepts

scientific article published on 21 March 2011

Correction to: JAK Inhibitors for Atopic Dermatitis: An Update

scientific article published on 01 April 2019

Correction to: Qualitative Assessment of Adult Patients' Perception of Atopic Dermatitis Using Natural Language Processing Analysis in a Cross-Sectional Study

scientific article published on 01 April 2020

Crisaborole Topical Ointment, 2%: A Nonsteroidal, Topical, Anti-Inflammatory Phosphodiesterase 4 Inhibitor in Clinical Development for the Treatment of Atopic Dermatitis

scientific article published on April 2016

Crisaborole and atopic dermatitis skin biomarkers: An intrapatient randomized trial

scientific article published on 13 August 2019

Cross-sectional study of blood biomarkers of patients with moderate-to-severe alopecia areata reveals systemic immune and cardiovascular biomarker dysregulation

scientific article published on 03 May 2020

Current and emerging biologic and small molecule therapies for atopic dermatitis

scientific article published on 07 February 2019

Cutaneous p38 mitogen-activated protein kinase activation triggers psoriatic dermatitis

scientific article published on 01 August 2019

Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology.

scientific article

Cytokine Targeted Therapeutics for Alopecia Areata: Lessons from Atopic Dermatitis and Other Inflammatory Skin Diseases

scientific article published in January 2018

Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches

scientific article

Distinct transcriptomic profiles of early-onset atopic dermatitis in blood and skin of pediatric patients

scientific article published on 01 December 2018

Diverse activation and differentiation of multiple B-cell subsets in patients with atopic dermatitis but not in patients with psoriasis.

scientific article published on 2 October 2015

Drug evaluation review: dupilumab in atopic dermatitis

scientific article

Drugs for the Treatment of Chronic Hand Eczema: Successes and Key Challenges

scientific article published on 31 December 2020

Dupilumab Significantly Modulates Pain and Discomfort in Patients With Atopic Dermatitis: A Post Hoc Analysis of 5 Randomized Clinical Trials

scientific article published on 05 November 2020

Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis

scientific article published on December 2014

Dupilumab progressively improves systemic and cutaneous abnormalities in atopic dermatitis patients

scientific article published on 05 September 2018

Dupilumab treatment in adults with moderate-to-severe atopic dermatitis

scientific article published on 01 July 2014

Early pediatric atopic dermatitis shows only a cutaneous lymphocyte antigen (CLA)(+) TH2/TH1 cell imbalance, whereas adults acquire CLA(+) TH22/TC22 cell subsets

scientific article published on August 2015

Early-onset pediatric atopic dermatitis is TH2 but also TH17 polarized in skin

scientific article published on 15 September 2016

Early-onset pediatric atopic dermatitis is characterized by TH2/TH17/TH22-centered inflammation and lipid alterations

scientific article published on 03 May 2018

Effect of therapeutic integrin (CD11a) blockade with efalizumab on immune responses to model antigens in humans: results of a randomized, single blind study

scientific article

Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes

scientific article

Effective use of ustekinumab in a patient with concomitant psoriasis, vitiligo, and alopecia areata

scientific article published on 23 September 2017

Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis: A Phase 3 Randomized Clinical Trial

scientific article published on 06 November 2019

Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis: A Phase 2b Randomized Clinical Trial

scientific article published on 26 February 2020

Efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: a systematic review for the EAACI Biologicals Guidelines

scientific article published on 21 July 2020

Efficacy and safety of fezakinumab (an anti-IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments - A randomized, double-blind, phase 2a trial

scientific article published on 15 January 2018

Efficacy and safety of secukinumab treatment in adults with extensive alopecia areata

scientific article published on 18 August 2018

Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria - a systematic review for the EAACI Biologicals Guidelines

scientific article published on 07 August 2020

Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitis

scientific article published on 15 June 2016

Efficacy of biologics in atopic dermatitis

scientific article published on 03 February 2020

Endophenotypic Variations of Atopic Dermatitis by Age, Race, and Ethnicity

scientific article published on 01 June 2020

Evolution of pathologic T-cell subsets in patients with atopic dermatitis from infancy to adulthood

scientific article published on 15 October 2019

Expert Perspectives on Management of Moderate-to-Severe Atopic Dermatitis: A Multidisciplinary Consensus Addressing Current and Emerging Therapies

scientific article published on 29 September 2017

Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism

scientific article published on 20 November 2015

FRT - Fondation Rene Touraine

Familial clustering of classic Kaposi sarcoma

scientific article

GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis

scientific article published on 06 February 2019

Granuloma annulare skin profile shows activation of T-helper cell type 1, T-helper cell type 2, and Janus kinase pathways

scientific article published on 20 December 2019

Health-related quality of life with tralokinumab in moderate-to-severe atopic dermatitisA phase 2b randomized study

scientific article published on 14 December 2020

Human and computational models of atopic dermatitis: a review and perspectives by an expert panel of the International Eczema Council

scientific article published on 07 November 2018

Human basal cell carcinoma is associated with Foxp3+ T cells in a Th2 dominant microenvironment.

scientific article

Human telomerase RNA component expression in Spitz nevi, common melanocytic nevi, and malignant melanomas

scientific article published on 01 July 2002

IL-17 induces an expanded range of downstream genes in reconstituted human epidermis model

scientific article

IL-17C: A Unique Epithelial Cytokine with Potential for Targeting across the Spectrum of Atopic Dermatitis and Psoriasis

scientific article published on 01 July 2018

IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells

scientific article

IL-4Rα Blockade by Dupilumab Decreases Staphylococcus aureus Colonization and Increases Microbial Diversity in Atopic Dermatitis

scientific article published on 25 June 2019

IL32 is progressively expressed in mycosis fungoides independent of helper T-cell 2 and helper T-cell 9 polarization.

scientific article

Ichthyosis molecular fingerprinting shows profound TH17 skewing and a unique barrier genomic signature

scientific article published on 24 May 2018

Identification of novel immune and barrier genes in atopic dermatitis by means of laser capture microdissection.

scientific article published on January 2015

Immune Pathways in Atopic Dermatitis, and Definition of Biomarkers through Broad and Targeted Therapeutics

scientific article

Immunologic, microbial, and epithelial interactions in atopic dermatitis

scientific article

Improving evaluation of drugs in atopic dermatitis by combining clinical and molecular measures

scientific article published on 20 July 2020

Increased cardiovascular and atherosclerosis markers in blood of older patients with atopic dermatitis

scientific article published on 14 October 2019

Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic Disorder.

scientific article published on 20 October 2016

Infection with Kaposi's sarcoma-associated herpesvirus among families of patients with classic Kaposi's sarcoma.

scientific article published on November 2005

Integrative responses to IL-17 and TNF-α in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis

scientific article

International observational atopic dermatitis cohort to follow natural history and treatment course: TARGET-DERM AD study design and rationale

scientific article published on 27 November 2020

Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis.

scientific article published on 15 June 2013

JAK Inhibitors for Atopic Dermatitis: An Update

scientific article published on 01 April 2019

Kallikrein 7 Promotes Atopic Dermatitis-Associated Itch Independently of Skin Inflammation

scientific article published on 26 December 2019

Kaposi's sarcoma-associated herpesvirus: clinical, diagnostic, and epidemiological aspects

scientific article

Lesional dendritic cells in patients with chronic atopic dermatitis and psoriasis exhibit parallel ability to activate T-cell subsets.

scientific article published on 25 June 2011

Low expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasis

scientific article

Major Differences in Expression of Inflammatory Pathways in Skin from Different Body Sites of Healthy Individuals

scientific article published on 03 May 2019

Major differences between human atopic dermatitis and murine models, as determined by using global transcriptomic profiling

scientific article

Major differences in inflammatory dendritic cells and their products distinguish atopic dermatitis from psoriasis.

scientific article published on May 2007

Mechanisms of contact sensitization offer insights into the role of barrier defects vs. intrinsic immune abnormalities as drivers of atopic dermatitis

scientific article published on October 2013

Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathways

scientific article published on 12 October 2015

Mild atopic dermatitis lacks systemic inflammation, and shows reduced non-lesional skin abnormalities

scientific article published on 01 October 2020

Moderate-to-severe atopic dermatitis patients show increases in serum C-reactive protein levels, correlating with skin disease activity

scientific article published on 20 September 2017

Molecular and Cellular Profiling of Scalp Psoriasis Reveals Differences and Similarities Compared to Skin Psoriasis

scientific article published on 5 February 2016

Molecular profiling of contact dermatitis skin identifies allergen-dependent differences in immune response.

scientific article

Molecular signatures order the potency of topically applied anti-inflammatory drugs in patients with atopic dermatitis

scientific article published on 23 February 2017

Monoclonal antibodies for the treatment of atopic dermatitis

scientific article published on 01 August 2018

Myeloid dendritic cells from human cutaneous squamous cell carcinoma are poor stimulators of T-cell proliferation

scientific article

New era of biologic therapeutics in atopic dermatitis

scientific article

New pathogenic and therapeutic paradigms in atopic dermatitis

scientific article published on 23 December 2014

New treatments for atopic dermatitis targeting beyond IL-4/IL-13 cytokines

scientific article published on 14 October 2019

Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities

scientific article

Nonlesional atopic dermatitis skin shares similar T-cell clones with lesional tissues

scientific article

Novel concepts of prevention and treatment of atopic dermatitis through barrier and immune manipulations with implications for the atopic march

scientific article published on June 2017

Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis

scientific article published on 26 July 2019

Patch testing of food allergens promotes Th17 and Th2 responses with increased IL-33: a pilot study.

scientific article published on 10 January 2017

Patients with atopic dermatitis have attenuated and distinct contact hypersensitivity responses to common allergens in skin.

scientific article published on 10 January 2015

Perivascular leukocyte clusters are essential for efficient activation of effector T cells in the skin

scientific article published on 21 September 2014

Petrolatum: Barrier repair and antimicrobial responses underlying this "inert" moisturizer.

scientific article

Phase 2 Randomized, Double-blind Study of IL-17-Targeting with Secukinumab in Atopic Dermatitis

scientific article published on 16 May 2020

Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis

scientific article published on 27 August 2012

Prostaglandin E2 stimulates adaptive IL-22 production and promotes allergic contact dermatitis

scientific article published on 2 June 2017

Protocol for a prospective, observational, longitudinal study in paediatric patients with moderate-to-severe atopic dermatitis (PEDISTAD): study objectives, design and methodology

scientific article published on 24 March 2020

Qualitative Assessment of Adult Patients' Perception of Atopic Dermatitis Using Natural Language Processing Analysis in a Cross-Sectional Study

scientific article published on 31 January 2020

RNA Sequencing Keloid Transcriptome Associates Keloids With Th2, Th1, Th17/Th22, and JAK3-Skewing

scientific article published on 23 November 2020

RNA sequencing atopic dermatitis transcriptome profiling provides insights into novel disease mechanisms with potential therapeutic implications.

scientific article published on 31 March 2015

Racial differences in atopic dermatitis

scientific article published on 20 November 2018

Real-world evidence of dupilumab efficacy and risk of adverse events: a systematic review and meta-analysis

scientific article published on 18 August 2020

Real-world persistence with dupilumab among adults with atopic dermatitis

scientific article published on 30 July 2020

Relationship between human herpesvirus 8 loads and disease stage in classic Kaposi sarcoma patients

scientific article published on 01 April 2007

Reply

scientific article published on 08 April 2016

Reply: To PMID 25748064

scientific article published on 10 October 2015

Report from the National Institute of Allergy and Infectious Diseases workshop on "Atopic dermatitis and the atopic march: Mechanisms and interventions"

scientific article published on 09 January 2019

Report from the National Institute of Allergy and Infectious Diseases workshop on drug allergy

scientific article

Residual genomic profile after cyclosporine treatment may offer insights into atopic dermatitis reoccurrence

scientific article

Residual genomic signature of atopic dermatitis despite clinical resolution with narrow-band UVB.

scientific article

Response to "Comment on: 'When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council'"

scientific article published on 01 August 2018

Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response

scientific article

Role of IL-23 in the pathogenesis of psoriasis: a novel potential therapeutic target?

scientific article published on 25 February 2014

SARS-CoV-2 receptorACE2 protein expression in serum is significantly associated with age

scientific article published on 29 July 2020

Selective JAK1 Inhibitors for the Treatment of Atopic Dermatitis: Focus on Upadacitinib and Abrocitinib

scientific article published on 10 August 2020

Selective sweep for an enhancer involucrin allele identifies skin barrier adaptation out of Africa

scientific article published on 07 May 2021

Serum from Asian patients with atopic dermatitis is characterized by TH2/TH22 activation, which is highly correlated with nonlesional skin measures.

scientific article published on 10 April 2018

Severe atopic dermatitis is characterized by selective expansion of circulating TH2/TC2 and TH22/TC22, but not TH17/TC17, cells within the skin-homing T-cell population

scientific article published on 3 March 2015

Short-term LXR activation improves epidermal barrier features in mild-to-moderate atopic dermatitis: a randomized controlled trial.

scientific article published on 19 March 2018

Single-cell analysis of human skin identifies CD14+ type 3 dendritic cells co-producing IL1B and IL23A in psoriasis

scientific article published in 2021

Single-cell transcriptome analysis of human skin identifies novel fibroblast subpopulation and enrichment of immune subsets in atopic dermatitis

scientific article published on 07 February 2020

Skin barrier and immune dysregulation in atopic dermatitis: an evolving story with important clinical implications

scientific article published on 25 April 2014

Skin-homing and systemic T-cell subsets show higher activation in atopic dermatitis versus psoriasis

scientific article published in May 2015

Successful treatment of juvenile pityriasis rubra pilaris with ustekinumab in a 7-year-old girl.

scientific article

Successful use of ustekinumab therapy in refractory severe atopic dermatitis

scientific article

Systemic Therapies for Moderate-to-Severe Atopic Dermatitis: Expert Perspectives in Practice

scientific article published on 01 February 2019

Systemic immune mechanisms in atopic dermatitis and psoriasis with implications for treatment

scientific article published on 7 March 2017

Systemic therapies in atopic dermatitis: The pipeline

scientific article published on 23 March 2017

TNF-α downregulates filaggrin and loricrin through c-Jun N-terminal kinase: role for TNF-α antagonists to improve skin barrier.

scientific article

Tape strips detect distinct immune and barrier profiles in atopic dermatitis and psoriasis

scientific article published on 09 July 2020

Tape-Strip Proteomic Profiling of Atopic Dermatitis on Dupilumab Identifies Minimally Invasive Biomarkers

scientific article published on 06 August 2020

Tape-strips from early-onset pediatric atopic dermatitis highlight disease abnormalities in non-lesional skin

scientific article published on 08 July 2020

Tape-strips provide a minimally-invasive approach to track therapeutic response to topical corticosteroids in atopic dermatitis patients

scientific article published on 01 September 2020

The 'omics' revolution: redefining the understanding and treatment of allergic skin diseases

scientific article

The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization

scientific article published on 28 September 2015

The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm

scientific article

The Erythema Q-score, an Imaging Biomarker for Redness in Skin Inflammation

scientific article published on 28 October 2020

The Major Orphan Forms of Ichthyosis Are Characterized by Systemic T-Cell Activation and Th-17/Tc-17/Th-22/Tc-22 Polarization in Blood

scientific article published on 14 April 2018

The Unique Molecular Signatures of Contact Dermatitis and Implications for Treatment

scientific article published on 01 February 2019

The atopic dermatitis blood signature is characterized by increases in inflammatory and cardiovascular risk proteins.

scientific article published on 18 August 2017

The autologous serum skin test in a cohort of chronic idiopathic urticaria patients compared to respiratory allergy patients and healthy individuals

scientific article published on 01 January 2007

The blood proteomic signature of early-onset pediatric atopic dermatitis shows systemic inflammation and is distinct from adult long-standing disease

scientific article published on 19 April 2019

The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies

scientific article published on April 2017

The oral Janus kinase/spleen tyrosine kinase inhibitor ASN002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate-to-severe atopic dermatitis: results from a randomized double-blind placebo-controlled study

scientific article published on 06 May 2019

The proteomic skin profile of moderate-to-severe atopic dermatitis patients shows an inflammatory signature

scientific article published on 25 October 2019

The role of circulating eosinophils on COVID-19 mortality varies by race/ethnicity

scientific article published on 15 December 2020

The role of phosphodiesterase 4 in the pathophysiology of atopic dermatitis and the perspective for its inhibition

scientific article published on 12 December 2018

The skin as an immune organ: Tolerance versus effector responses and applications to food allergy and hypersensitivity reactions

scientific article published on 05 April 2019

The spectrum of manifestations in desmoplakin gene (DSP) spectrin repeat 6 domain mutations: Immunophenotyping and response to ustekinumab.

scientific article published on 21 October 2017

The translational revolution and use of biologics in patients with inflammatory skin diseases

scientific article published on 23 December 2014

The translational revolution in atopic dermatitis, and how it also translates to other inflammatory skin diseases.

scientific article

Topical agents for the treatment of atopic dermatitis

scientific article published on 08 January 2019

Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2)

scientific article published on 30 September 2020

Treatment of atopic dermatitis with tralokinumab, an anti-IL-13 mAb

scientific article published on 12 June 2018

Treatment of severe chronic idiopathic urticaria with oral mycophenolate mofetil in patients not responding to antihistamines and/or corticosteroids

article by Eduardo Shahar et al published October 2006 in International Journal of Dermatology

Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis

scientific article published on 30 September 2016

Understanding the immune landscape in atopic dermatitis: The era of biologics and emerging therapeutic approaches

scientific article published on 15 April 2019

Upadacitinib in adults with moderate to severe atopic dermatitis: 16-week results from a randomized, placebo-controlled trial

scientific article published on 29 November 2019

Use of 308 nm excimer laser for the treatment of chronic hand and foot eczema

scientific article

Use of Tape Strips to Detect Immune and Barrier Abnormalities in the Skin of Children With Early-Onset Atopic Dermatitis

scientific article published on 09 October 2019

Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement

scientific article published on 2 September 2017

What's New in Atopic Dermatitis

scientific article published on 16 February 2019

When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council.

scientific article published on 10 August 2017

Whole genome sequencing identifies novel genetic mutations in patients with eczema herpeticum

scientific article published on 15 March 2021

Whole-Genome Sequencing Identifies STAT4 as a Putative Susceptibility Gene in Classic Kaposi Sarcoma

scientific article published on 9 December 2014